Cargando…
Screening for Lyme Disease with C6 Peptide at a Veterans Hospital in Long Island, NY
BACKGROUND: Lyme Disease (LD) is an endemic disease in Long Island, NY caused by Borrelia burgdorferi. The CDC recommends a two tier system for diagnosis of LD, a screening immunoassay followed by confirmatory Western Blot (WB). The C6 peptide (C6P) is a very sensitive screening test for LD and is c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630714/ http://dx.doi.org/10.1093/ofid/ofx163.1544 |